Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ReNeuron raises funds as it awaits review from first treatment of stem cell therapy

This article was originally published in Scrip

Executive Summary

ReNeuron has raised £10 million by means of a share placing and subscription with new and existing investors on London's AIM. The stem cell-focused company says the financing provides preclinical and clinical development funding for core therapeutic programmes for the next two years, after which it believes that out-licensing deals will be possible for these programmes.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC011114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel